Ozempic Pill and Rybelsus: What the Tablet Label Says

Short answer: The “Ozempic pill” is Ozempic® (semaglutide) tablets, a once-daily tablet that shares one prescribing label with Rybelsus®, the older semaglutide tablet. Both are approved for adults with type 2 diabetes, to improve blood sugar and to lower the risk of major heart events in those at high risk. Neither is approved for weight loss; the semaglutide tablet with a weight indication is Wegovy®. This page summarizes the shared label and Medication Guide, without strengths or how a prescriber adjusts them.

Is there an Ozempic pill?

Yes. On Drugs@FDA, the application for semaglutide tablets (NDA 213051) now lists two brand names, Ozempic and Rybelsus, and records a labeling approval dated January 30, 2026. The label on DailyMed with that effective date is titled for both products and refers throughout to “RYBELSUS and OZEMPIC tablets.”

The medicine in both is semaglutide, the same GLP-1 receptor agonist that is in Ozempic injection and Wegovy. For what the class does, see What is a GLP-1?.

What is the difference between Ozempic tablets and Rybelsus?

The two tablets carry the same uses, the same instructions and the same warnings. They differ in the tablet itself.

	Ozempic tablets	Rybelsus
Medicine	Semaglutide	Semaglutide
Tablet shape (Section 16)	Round, white to light yellow, “novo” on one side	Oval, white to light yellow, “novo” on one side
Inactive ingredients (Section 11)	Magnesium stearate and SNAC	Magnesium stearate, microcrystalline cellulose, povidone and SNAC
Estimated share of semaglutide absorbed (Section 12.3)	About 1% to 2%	About 0.4% to 1%
How it is taken	Same steps	Same steps

Because more of the medicine is absorbed from an Ozempic tablet, each Ozempic tablet contains less semaglutide than the Rybelsus tablet it is matched with. In a study in healthy adults, the label reports no clinically significant difference in blood levels between the matched tablets. That is why Section 2.1 opens with this line: “RYBELSUS and OZEMPIC tablets are not substitutable on a mg-to-mg basis.” The number printed on one bottle does not mean the same thing on the other.

The label also limits when someone can move from one tablet to the other and gives prescribers a matching table. A switch is a prescription change, so do not swap bottles on your own. If a refill looks different from your last one (round instead of oval, or the other way around), ask your pharmacist before taking it.

Is the Ozempic pill approved for weight loss?

No. Section 1 lists two uses for Rybelsus and Ozempic tablets:

• “as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.”
• “to reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events.”

The semaglutide tablet with a weight indication is Wegovy tablets. The Wegovy label (effective June 18, 2026) says Wegovy tablets are indicated “to reduce excess body weight and maintain weight reduction long term” in adults with obesity, or with overweight and at least one weight-related condition, and to reduce the risk of major heart events in adults with established heart disease and obesity or overweight. For that tablet, see Wegovy pill: what the label says. The Medication Guide for the Ozempic and Rybelsus tablets says: “Do not use RYBELSUS or OZEMPIC tablets for a condition for which it was not prescribed.”

How is the Ozempic pill taken?

Section 2.1 of the label says:

• Take one tablet by mouth once daily “on an empty stomach in the morning with water (up to 4 ounces of water).” Do not take it with other liquids.
• “Do not take more than one tablet per day.”
• “Swallow tablets whole. Do not split, crush, chew or dissolve in any solution.”
• After the tablet, “wait at least 30 minutes before eating food, drinking beverages or taking other oral medications.”

The label sets a stepwise schedule of tablet strengths. Your prescriber manages that schedule, so it is not covered here. For what to do about a missed tablet, follow your Medication Guide and your prescriber.

Why the strict morning routine? Section 12.3 says the tablets are made with an ingredient called SNAC “which facilitates the absorption of semaglutide,” and that absorption “predominantly occurs in the stomach.” In the studies it describes, absorption was higher with a small amount of water (50 mL) than with a full glass (240 mL), and higher after a longer wait before eating. If the steps are hard to fit into your morning, ask your prescriber or pharmacist.

How is the Ozempic pill different from the Ozempic shot?

Both contain semaglutide, but they are separate products with separate labels.

	Ozempic injection	Ozempic tablets
How often	Once weekly, on the same day each week	Once daily, in the morning
How it is taken	Under the skin of the stomach area, thigh or upper arm	By mouth, on an empty stomach, with up to 4 ounces of water
Uses in Section 1	Blood sugar in type 2 diabetes; lowering heart-event risk in type 2 diabetes with established heart disease; lowering the risk of kidney decline, kidney failure and heart death in type 2 diabetes with chronic kidney disease	Blood sugar in type 2 diabetes; lowering heart-event risk in type 2 diabetes at high risk
Storage	Refrigerator before first use; after first use, up to 56 days at 59°F to 86°F or in the refrigerator	Room temperature, 68°F to 77°F, in the original bottle
Breastfeeding	Label weighs benefits and risks	“Breastfeeding is not recommended”

The breastfeeding difference comes from SNAC. Section 8.2 of the tablet label says SNAC or its byproducts are present in human milk and that infants may clear it more slowly, and it points out that “there are alternative semaglutide products that do not contain SNAC that can be used during lactation.”

The tablet label describes how a prescriber may move someone from Ozempic injection to a tablet. For the pen and its needles, see Ozempic pen and needles, and for pills and shots across brands, see GLP-1 pills vs shots.

What side effects does the label report?

The label says the safety of Ozempic tablets rests on the trials of Rybelsus. Table 2 pools 2 placebo-controlled trials in adults with type 2 diabetes. It reports two strengths separately; the range below covers both.

Reported in at least 5% of patients on semaglutide tablets	Placebo	Semaglutide tablets
Nausea	6%	11% to 20%
Stomach (abdominal) pain	4%	10% to 11%
Diarrhea	4%	9% to 10%
Decreased appetite	1%	6% to 9%
Vomiting	3%	6% to 8%
Constipation	2%	5% to 6%

• Stomach and bowel effects overall. These occurred in 32% to 41% of patients on the tablets, compared with 21% on placebo. The label says most nausea, vomiting and diarrhea happened while the strength was being increased.
• Stopping treatment. 4% to 8% of patients on the tablets stopped because of stomach and bowel side effects, compared with 1% on placebo.
• Low blood sugar. The label says it was more frequent when the tablets were used with a sulfonylurea or insulin.

These numbers come from different trials than the injection and Wegovy labels, so they are not a head-to-head comparison. The label’s serious warnings include possible thyroid tumors (a boxed warning based on rodent studies), pancreatitis, vision changes in people with diabetic eye disease, kidney problems from dehydration, gallbladder problems, serious allergic reactions, and food or liquid getting into the lungs during anesthesia or deep sedation. For each effect in more depth, see GLP-1 side effects.

Does the Ozempic pill interact with other medicines?

Section 7 lists two kinds of interactions:

• Insulin or a sulfonylurea. Taking them together can raise the risk of low blood sugar, and the label says prescribers may consider lowering those medicines when the tablets are started.
• Other medicines taken by mouth. Semaglutide slows stomach emptying, which “has the potential to impact the absorption of other oral drugs.” In one study, levothyroxine (a thyroid medicine) exposure was 33% higher when taken with semaglutide tablets. For medicines that need close monitoring, the label suggests extra checks.

The 30-minute wait after the tablet applies to other oral medicines too. The Medication Guide asks you to tell your healthcare provider about all the medicines you take, including over-the-counter medicines, vitamins and herbal supplements, and says: “Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.”

What does the label say about pregnancy?

The Medication Guide says: “You should stop using RYBELSUS or OZEMPIC tablets 2 months before you plan to become pregnant.” Section 8.3 gives the reason as “the long washout period for semaglutide.” Section 12.3 says semaglutide has an elimination half-life of about one week and “is present in the circulation for about five weeks after the last semaglutide tablet dose.” For more on half-life, see how long GLP-1 medicines stay in your system.

How should Ozempic tablets be stored?

The Medication Guide says to store the tablets at room temperature, between 68°F and 77°F, in a dry place, and to keep them “in the original closed RYBELSUS or OZEMPIC bottle until you are ready to take one. Do not store in any other container.” By that wording, moving tablets into a pill organizer does not follow the label; ask your pharmacist if you travel or need another way to carry them.

Does Medicare cover the Ozempic pill?

Medicare.gov says that for people with type 2 diabetes, “your Medicare drug plan should cover GLP-1 medications to treat these conditions.” Ozempic and Rybelsus are not on the separate Medicare GLP-1 Bridge list, which covers weight-related use of Foundayo®, Wegovy (injection or tablet) and Zepbound KwikPen. Plans and rules vary, so see Does Medicare cover GLP-1 drugs? and check with your plan.

How can you keep track?

A daily tablet with a 30-minute wait is easy to forget and easy to doubt later. A short note of the day and time you took it, and how you felt, helps at appointments, especially after a strength change or a switch between tablets. Weeko, a shot tracker coming to iPhone and Android, is being built around this kind of simple log. It is a logbook, not medical guidance.

When to call your doctor

Before you start, the Medication Guide asks you to tell your healthcare provider if you have or have had problems with your pancreas or kidneys, a history of vision problems related to diabetes, a surgery or procedure planned with anesthesia or deep sedation, or if you are pregnant, plan to become pregnant or are breastfeeding. Ask before switching between Rybelsus and Ozempic tablets, or between the injection and a tablet.

Stop taking the tablets and call your healthcare provider right away if you have severe pain in your stomach area that will not go away, with or without nausea or vomiting. Tell your healthcare provider right away about nausea, vomiting or diarrhea that does not go away, and about gallbladder symptoms (upper stomach pain, fever, yellowing of the skin or eyes, clay-colored stools). Tell your healthcare provider about changes in vision, or a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Stop the tablets and get medical help right away for signs of a serious allergic reaction, such as swelling of the face, lips, tongue or throat, or trouble breathing or swallowing. If you take too much, call your healthcare provider or Poison Help at 1-800-222-1222, or go to the nearest emergency room right away.